ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 195 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $835,627 | -64.8% | 74,810 | +49.1% | 0.00% | -60.0% |
Q2 2022 | $2,371,000 | +227.9% | 50,160 | +418.7% | 0.01% | +400.0% |
Q4 2021 | $723,000 | +72.6% | 9,670 | -2.8% | 0.00% | -50.0% |
Q4 2020 | $419,000 | -73.8% | 9,952 | -71.5% | 0.00% | -80.0% |
Q3 2020 | $1,599,000 | -75.8% | 34,934 | -73.5% | 0.01% | -78.3% |
Q2 2020 | $6,619,000 | -48.9% | 131,824 | -47.7% | 0.05% | -64.3% |
Q1 2020 | $12,959,000 | +15.9% | 251,961 | +39.2% | 0.13% | +67.5% |
Q4 2019 | $11,186,000 | +8.0% | 181,055 | +5.0% | 0.08% | -4.9% |
Q3 2019 | $10,356,000 | -20.2% | 172,373 | +12.1% | 0.08% | -24.3% |
Q2 2019 | $12,977,000 | -53.0% | 153,786 | -46.8% | 0.11% | -17.7% |
Q1 2019 | $27,598,000 | +156.5% | 288,906 | +90.2% | 0.13% | +18.2% |
Q4 2018 | $10,759,000 | +59.9% | 151,891 | +92.9% | 0.11% | +279.3% |
Q3 2018 | $6,730,000 | +475.2% | 78,744 | +202.7% | 0.03% | +93.3% |
Q2 2015 | $1,170,000 | -69.0% | 26,016 | -78.9% | 0.02% | -69.4% |
Q1 2015 | $3,780,000 | -61.8% | 123,457 | -36.6% | 0.05% | -62.6% |
Q4 2014 | $9,902,000 | -20.9% | 194,728 | -38.5% | 0.13% | -27.6% |
Q3 2014 | $12,521,000 | +8973.2% | 316,426 | +9742.2% | 0.18% | +8950.0% |
Q2 2014 | $138,000 | – | 3,215 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |